Select Publications
Journal articles
2021, '319Congenital cytomegalovirus education, translation and prevention', International Journal of Epidemiology, 50, http://dx.doi.org/10.1093/ije/dyab168.688
,2021, 'A placental specific miRNA miR-517a-3p exerts anti-human cytomegalovirus activity', Placenta, 112, pp. 62 - 65, http://dx.doi.org/10.1016/j.placenta.2021.06.013
,2021, 'Optimization of blood handling and peripheral blood mononuclear cell cryopreservation of low cell number samples', International Journal of Molecular Sciences, 22, http://dx.doi.org/10.3390/ijms22179129
,2021, 'The virome in early life and childhood and development of islet autoimmunity and type 1 diabetes: A systematic review and meta-analysis of observational studies', Reviews in Medical Virology, 31, pp. 1 - 14, http://dx.doi.org/10.1002/rmv.2209
,2021, 'Genomics-informed responses in the elimination of COVID-19 in Victoria, Australia: an observational, genomic epidemiological study', The Lancet Public Health, 6, pp. e547 - e556, http://dx.doi.org/10.1016/S2468-2667(21)00133-X
,2021, 'IFCC interim guidelines on rapid point-of-care antigen testing for SARS-CoV-2 detection in asymptomatic and symptomatic individuals', Clinical Chemistry and Laboratory Medicine, 59, pp. 1507 - 1515, http://dx.doi.org/10.1515/cclm-2021-0455
,2021, 'Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study', The Lancet Gastroenterology and Hepatology, 6, pp. 533 - 546, http://dx.doi.org/10.1016/S2468-1253(21)00077-7
,2021, 'SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants', PLoS Medicine, 18, http://dx.doi.org/10.1371/journal.pmed.1003656
,2021, 'Viruses and type 1 diabetes: From enteroviruses to the virome', Microorganisms, 9, http://dx.doi.org/10.3390/microorganisms9071519
,2021, 'Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection', Cell Reports Medicine, 2, pp. 100228, http://dx.doi.org/10.1016/j.xcrm.2021.100228
,2021, 'Contextualising SARS Coronavirus 2 and COVID-19', Microbiology Australia, 42, pp. 3, http://dx.doi.org/10.1071/MA21002
,2021, 'Cepheid Xpert® Flu/RSV and Seegene Allplex™ RP1 show high diagnostic agreement for the detection of influenza A/B and respiratory syncytial viruses in clinical practice', Influenza and other Respiratory Viruses, 15, pp. 245 - 253, http://dx.doi.org/10.1111/irv.12799
,2021, 'Sars coronavirus-2 microneutralisation and commercial serological assays correlated closely for some but not all enzyme immunoassays', Viruses, 13, http://dx.doi.org/10.3390/v13020247
,2021, 'Investigational antiviral therapy models for the prevention and treatment of congenital cytomegalovirus infection during pregnancy', Antimicrobial Agents and Chemotherapy, 65, pp. 10.1128/aac.01627 - 10.1128/aac.01620, http://dx.doi.org/10.1128/AAC.01627-20
,2021, 'Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies', mAbs, 13, http://dx.doi.org/10.1080/19420862.2021.1922134
,2021, 'Selection and use of respiratory protection by healthcare workers to protect from infectious diseases in hospital settings', Annals of Work Exposures and Health, 64, pp. 368 - 377, http://dx.doi.org/10.1093/ANNWEH/WXAA020
,2021, 'Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351/501Y-V2', Wellcome Open Research, 6, http://dx.doi.org/10.12688/wellcomeopenres.16661.1
,2021, 'Ageing impairs the airway epithelium defence response to SARS-CoV-2', , http://dx.doi.org/10.1101/2021.04.05.437453
,2021, 'Assessment of inter-laboratory differences in SARS-CoV-2 consensus genome assemblies between public health laboratories in Australia', , http://dx.doi.org/10.1101/2021.08.19.21262296
,2021, 'Background, testing methods, and laboratory approaches to SARS coronavirus-2 (SARS-CoV-2) and covid19', Pathology, 53, pp. S17 - S17, http://dx.doi.org/10.1016/j.pathol.2021.05.060
,2021, 'Background, testing methods, and laboratory approaches to SARS coronavirus-2 (SARS-CoV-2) and Covid19', Pathology, 53, pp. S7 - S7, http://dx.doi.org/10.1016/j.pathol.2021.05.025
,2021, 'Background, testing methods, and laboratory approaches to sars coronavirus-2 (SARS-CoV-2) and covid19', Pathology, 53, pp. S2 - S3, http://dx.doi.org/10.1016/j.pathol.2021.05.006
,2021, 'IFCC Interim Guidelines on Biochemical/ Hematological Monitoring of COVID-19 Patients', Laboratornaya sluzhba, 10, pp. 55 - 55, http://dx.doi.org/10.17116/labs20211004155
,2021, 'Rapid spread of a SARS-CoV-2 Delta variant with a frameshift deletion in ORF7a', , http://dx.doi.org/10.1101/2021.08.18.21262089
,2021, 'Viruses and Type 1 Diabetes: From Enteroviruses to the Virome', , http://dx.doi.org/10.20944/preprints202106.0574.v1
,2020, 'SARS-CoV-2 neutralizing antibodies; longevity, breadth, and evasion by emerging viral variants', , http://dx.doi.org/10.1101/2020.12.19.20248567
,2020, 'New Blood Borne Virus Infections Among Organ Transplant Recipients: A Data-Linked Cohort Study Examining Transmissions and De Novo Infections', International Journal of Population Data Science, 5, http://dx.doi.org/10.23889/ijpds.v5i5.1642
,2020, 'Vaccine-Preventable Infections Among Solid Organ Transplant Recipients: A Data-Linked Cohort Study, Australia, 2000-2015', International Journal of Population Data Science, 5, http://dx.doi.org/10.23889/ijpds.v5i5.1643
,2020, 'Analytical validity of nanopore sequencing for rapid SARS-CoV-2 genome analysis', Nature Communications, 11, http://dx.doi.org/10.1038/s41467-020-20075-6
,2020, 'Differential Expression of PDGF Receptor-α in Human Placental Trophoblasts Leads to Different Entry Pathways by Human Cytomegalovirus Strains', Scientific Reports, 10, pp. 1082, http://dx.doi.org/10.1038/s41598-020-57471-3
,2020, 'Fetal therapies for cytomegalovirus: What we tell prospective parents', Prenatal Diagnosis, 40, pp. 1681 - 1692, http://dx.doi.org/10.1002/pd.5692
,2020, 'Focus on SARS-CoV-2 and COVID-19', Pathology, 52, pp. 743 - 744, http://dx.doi.org/10.1016/j.pathol.2020.09.010
,2020, 'Laboratory biosafety measures involving SARS-CoV-2 and the classification as a Risk Group 3 biological agent', Pathology, 52, pp. 790 - 795, http://dx.doi.org/10.1016/j.pathol.2020.09.006
,2020, 'Laboratory diagnosis of severe acute respiratory syndrome coronavirus 2', Pathology, 52, pp. 745 - 753, http://dx.doi.org/10.1016/j.pathol.2020.09.011
,2020, 'New blood-borne virus infections among organ transplant recipients: An Australian data-linked cohort study examining donor transmissions and other HIV, hepatitis C and hepatitis B notifications, 2000-2015', Transplant Infectious Disease, 22, http://dx.doi.org/10.1111/tid.13437
,2020, 'SARS-CoV-2 in human milk is inactivated by Holder pasteurisation but not cold storage', Journal of Paediatrics and Child Health, 56, pp. 1872 - 1874, http://dx.doi.org/10.1111/jpc.15065
,2020, 'Virus isolation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for diagnostic and research purposes', Pathology, 52, pp. 760 - 763, http://dx.doi.org/10.1016/j.pathol.2020.09.012
,2020, 'IFCC Interim Guidelines on Biochemical/Hematological Monitoring of COVID-19 Patients', Clinical Chemistry and Laboratory Medicine, 58, pp. 2009 - 2016, http://dx.doi.org/10.1515/cclm-2020-1414
,2020, 'IFCC Interim Guidelines on Molecular Testing of SARS-CoV-2 Infection', Clinical Chemistry and Laboratory Medicine, 58, pp. 1993 - 2000, http://dx.doi.org/10.1515/cclm-2020-1412
,2020, 'IFCC Interim Guidelines on Serological Testing of Antibodies against SARS-CoV-2', Clinical Chemistry and Laboratory Medicine, 58, pp. 2001 - 2008, http://dx.doi.org/10.1515/cclm-2020-1413
,2020, 'Evaluation of commercially available viral transport medium (VTM) for SARS-CoV-2 inactivation and use in point-of-care (POC) testing', Viruses, 12, pp. 1208, http://dx.doi.org/10.3390/v12111208
,2020, 'A decade of RCPAQAP Biosecurity improving testing for biological threats in Australia', Microbiology Australia, 41, pp. 145 - 149, http://dx.doi.org/10.1071/MA20039
,2020, 'A quantitative nuclear egress assay to investigate the nucleocytoplasmic capsid release of human cytomegalovirus', Journal of Virological Methods, 283, http://dx.doi.org/10.1016/j.jviromet.2020.113909
,2020, 'Biological warfare: The history of microbial pathogens, biotoxins and emerging threats', Microbiology Australia, 41, pp. 116 - 122, http://dx.doi.org/10.1071/MA20031
,2020, 'Changes in pancreatic exocrine function in young at-risk children followed to islet autoimmunity and type 1 diabetes in the ENDIA study', Pediatric Diabetes, 21, pp. 945 - 949, http://dx.doi.org/10.1111/pedi.13056
,2020, 'The risk from Security Sensitive Biological Agents (SSBAs) and the need for response', Microbiology Australia, 41, pp. 115, http://dx.doi.org/10.1071/MA20030
,2020, 'Australian Paediatric Surveillance Unit (APSU) Annual Surveillance Report 2019', Communicable diseases intelligence (2018), 44, http://dx.doi.org/10.33321/cdi.2020.44.60
,2020, 'Pancreas size and exocrine function is decreased in young children with recent-onset Type 1 diabetes', Diabetic Medicine, 37, pp. 1340 - 1343, http://dx.doi.org/10.1111/dme.13987
,2020, 'Utility of rapid plasmin reagin titres in assessing treatment response and re-infection for infectious syphilis', Sexual Health, 17, pp. 330 - 336, http://dx.doi.org/10.1071/SH20043
,2020, 'Development, Implementation, and Evaluation of Treatment Guidelines for Herpes Simplex Keratitis in Sydney, Australia', Cornea, 39, pp. 834 - 840, http://dx.doi.org/10.1097/ICO.0000000000002273
,